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INTRODUCTION 
 
 Perinatal (Birth) Asphyxia describes a lack of oxygen, blood flow and 
gas exchange to fetus / new born.  Hypoxic Ischemic encephalopathy is an 
important consequence of perinatal hypoxia. 
 
 Birth asphyxia and Hypoxic ischemic encephalopathy(HIE) are 
associated with increased risk of mortality & morbidity. Mortality in a full 
term asphyxiated newborn is about 10-20%. 
 
 Early neonatal deaths are an important cause of the high infant 
mortality. Apart from Low Birth Weight & Neonatal infections asphyxia 
contributes a significant proportion of the mortality in early neonatal period. 
 
 HIE is associated with long term neurodevelopmental sequelae. Overall 
more severe the encephalopathy greater is the risk of sequelae. They may be 
major neurological sequelae like cerebral palsy, mental retardation, epilepsy, 
visual and auditory impairment or mild motor deficits in later life or subtle 
neurological abnormalities.   Even in the absence of obvious neurological 
deficits in newborn period there may be long term functional impairments.  
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Regular follow up of these babies helps in early identification of the 
developmental delay. Early identification and appropriate intervention may 
reduce the severity of later disability. 
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BIRTH ASPHYXIA &  HIE 
 
 Asphyxia refers to a combination of hypoxia, hypercarbia and metabolic 
acidosis. 
 
Definition : 
 American Academy of Pediatrics defines Perinatal Asphyxia as an insult 
to fetus or newborn due to a lack of oxygen (hypoxia) and or a lack of 
perfusion (ischemia) to various organs of sufficient magnitude & duration to 
produce more than fleeting functional and / or biochemical changes. 
 
Substantial & prolonged intrauterine Asphyxia is said to be present if   
a)  Documented Apgar score of 0-3 at 5 min       
b) Cord Umbilical artery pH of  <  7.0  and a base deficit of  > 12 
 
National Neonatology forum of India : 
 NNF suggested that birth asphyxia should be diagnosed when  
1. Baby has gasping and inadequate breathing or no breathing at 1 min. 
It is a simple & useful definition which can be used in community & 
corresponds to 1 min Apgar score of 3 or less. 
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APGAR SCORE 
Sign 0 1 2 
Heart rate Absent Slow< 100 bpm > 100 bpm 
Respiration Absent Slow, irregular Good, crying 
Muscle tone Limp Some flexion Active motion 
Reflex irritability 
(catheter in nares, tactile 
stimulation) 
No response Grimace Cough, sneeze, 
cry 
Color Blue or pale Pink body, blue 
extremities 
Completely pink 
  
 Low Apgar scores may be present in non asphyxiated infants also.  
Despite limitations, Apgar scoring is conventionally used to assess condition 
of newborn at 1 min after birth. 
 
Incidence of perinatal asphyxia : 
The incidence of perinatal asphyxia is about 1 to 1.5% of live births and 
is inversely related to gestational age and birth weight. 
 
Pathophysiology : 
In term neonates 90% of asphyxial insults occur antepartum or intrapartum 
due to placental insufficiency. 
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 During normal labour, uterine contractions, cord compression, increased 
O2 consumption by mother & fetus, maternal dehydration & alkalosis 
cause most babies to be born with little O2 reserve. 
 In addition to the above normal factors any process that 
1. impairs maternal oxygenation 
2. decreases blood flow from mother to fetus 
3. impairs gas exchange across placenta / in the fetus and 
4.  increase fetal O2 requirement     will increase risk of perinatal asphyxia 
In the presence of hypoxic ischemic challenge to fetus compensatory 
reflexes are  initiated causing shunting of blood to brain, heart and adrenals 
(diving reflex) 
 Target organs of perinatal asphyxia are brain, heart, lungs, kidney, liver, 
bowel and bone marrow. 
 
HYPOXIC ISCHEMIC ENCEPHALOPATHY 
 HIE is the most important consequence of perinatal asphyxia. Neonatal 
encephalopathy is defined as a state of altered level of consciouness 
without etiological implications. 
 
Hypoxic Ischemic Encephalopathy describes encephalopathy as defined 
above with objective evidence of hypoxia / ischemia (asphyxia) 
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 It should be emphasised that HIE is first one out of a number of 
etiologies in the differential diagnosis of neurological depression in 
neonate. 
 Asphyxia may be suspected and HIE reasonably included in differential 
diagnosis of neonatal depression / neurologic dysfunction if the following 
have been documented. 
1. 5 to 10 min  Apgar score  <  3 
2. Neonatal seizures within first 24 – 48 hrs 
3. Need for positive pressure resuscitation for more than 1 min or more 
than 5 min until first cry 
4. Burst suppression patterns on EEG 
5. Prolonged fetal acidosis 
 
Pathophysiology: 
 Brain hypoxia & ischemia from systemic hypoxemia and reduced 
cerebral blood flow are primary triggers of HIE. Initially compensatory 
increase in Cerebral Blood Flow occurs. 
 With prolonged asphyxia Cerebral Blood Flow becomes pressure 
passive. As BP falls  , brain hypoxia occurs leading to decrease in glycogen & 
ATP. There is a concomitant increase in lactate & fall in PH. 
 Following initial phase of energy failure   metabolism may recover only 
to deteriorate in second phase (delayed injury) 
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 Reperfusion injury is a second determinant of extent of brain damage.  
By 6-24 hrs after initial injury, a new phase characterized by apoptosis occurs. 
This phase may continue for days to week. 
 
Biochemical changes : 
 Both hypoxia & ischemia increase the release of excitotoxic aminoacids 
like glutamate. ExcitotoxicAminoacids through action at inotropic glutamate 
receptors (NMDA) open ion channels allowing Ca2+ and Na+ to enter cell 
inducing immediate neuronal death from osmolar load. 
 Further these excitotoxins by direct activation of NMDA channel 
provoke excessive Ca2+ influx.  This in turn leads to a delayed neuronal death 
by 
1. Activation of undesirable second messenger system. (lipases and 
proteases) 
2. Pertubation of mitochondrial respiratory electron chain transport 
3. Generation of free radicals & leukotrienes 
4. Generation of Nitric oxide 
Reperfusion of previously ischemic tissue promotes formation of excess 
oxygen free radicals.  (eg. Superoxide ion, hydrogen peroxide, hydroxyl 
radical) which may damage cellular lipids, proteins & nucleic acids. 
Reperfusion also brings with it neutrophils which along with activated 
microglia release injurious cytokines (IL – 1 β  & TNF -α   ) 
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Pathological Lesions : 
¾ Parasagittal cerebral necrosis :  This lesion is bilateral, usually 
symmetrical, and occurs in the cerebral cortex and subcortical white 
matter, especially in the parietooccipital region.  These regions 
represent the border zones of perfusion from major cerebral arteries.  
 
¾ Status marmoratus :  In this lesion, the basal ganglia, especially the 
caudate nucleus, putamen, and thalamus, demonstrate neuronal loss, 
gliosis, and hypermyelination, leading to a marble white 
discoloration of these regions. This is the least common type of 
neuropathology, and its full evolution may take months to years. 
 
¾ Focal and multifocal ischemic brain necrosis : These lesions are 
relatively large, localized areas of necrosis of cerebral parenchyma, 
cortex, and subcortical white matter.  The most frequently affected 
region is the zone perfused by the middle cerebral artery. 
 
¾ Periventricular leukomalacia :  This lesion is characterized by 
necrosis of white matter, seen grossly as white spots adjacent to the 
external angle of the lateral ventricles.  These sites are the border 
zones between penetrating branches of major cerebral arteries.  These 
lesions are more common in preterm than in term infants. 
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Clinical Manifestations of HIE : 
 The spectrum of HIE ranges from mild to severe.  The initial phase lasts 
for about 12 hrs after the insult & consists of signs of cerebral dysfunction. 
Clinical manifestations and course vary depending on HIE severity. 
 
* Mild HIE 
¾ Muscle tone may be increased slightly and deep tendon 
reflexes may be brisk during the first 24 hrs. 
¾ Transient behavioural abnormalities, such as poor feeding, 
irritability or excessive crying or sleepiness, may be 
observed. 
¾ By 1-2 days of life, the CNS examination findings become 
normal 
 
* Moderately severe HIE 
¾ The infant is lethargic, with significant hypotonia and diminished 
deep tendon reflexes. 
¾ The grasping, Moro, and sucking reflexes may be sluggish or 
absent. 
¾ The infant may experience occasional periods of apnea 
¾ Seizures may occur within first 24 hours of life 
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¾ Full recovery within 1-2 weeks is possible and is associated with 
a better long term outcome. 
¾ An initial period of well-being may be followed by sudden 
deterioration, suggesting reperfusion injury; during this period, 
seizure intensity might increase. 
 
* Severe HIE 
¾ Stupor or coma is typical.  The infant may not respond to any 
physical stimulus. 
¾ Breathing may be irregular, and the infant often requires 
ventilatory support. 
¾ Generalised hypotonia and depressed deep tendon reflexes are 
common. 
¾ Neonatal reflexes (eg. Sucking, swallowing, grasping, Moro) are 
absent. 
¾ Disturbances of ocular motion, such as skew deviation of the 
eyes, nystagmus, bobbing, and loss of “doll’s eye” (ie, conjugate) 
movements may be revealed by cranial nerve examination. 
¾ Pupils may be dilated, fixed, or poorly reactive to light 
¾ Seizures occur early and often and may be initially resistant to 
conventional treatments.  The seizures are usually generalized, 
and their frequency may increase during the 2-3 days after onset, 
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correlating with the phase of reperfusion injury. As the injury 
progresses, seizures subside and the EEG becomes isoelectric or 
shows a burst suppression pattern.  At that time, wakefulness may 
deteriorate further, and the fontanelle may bulge, suggesting 
increasing cerebral edema. 
¾ Irregularities of heart rate and BP are common during the period 
of reperfusion injury, as is death from cardio respiratory failure. 
 
* Infants who survive severe HIE 
¾ The level of alterness improves by days 4-5 of life 
¾ Hypotonia and feeding difficulties persist, requiring tube feeding 
for weeks to months. 
 
* Involvement of multiple organs besides the brain is a hall mark of HIE 
¾ Severely depressed respiratory and cardiac functions and signs of 
brainstem compression suggest a life- threatening rupture of the vein of 
Galen (ie. Great cerebral vein) with a hematoma in the posterior cranial 
fossa. 
¾ Reduced myocardial contractility, severe hypotension, passive cardiac 
dilatation, and tricuspid regurgitation are noted frequently in severe HIE 
¾ Patients may have severe pulmonary hypertension requiring assisted 
ventilation.  Renal failure presents as oliguria and during recovery, as 
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high output tubular failure, leading to significant water and electrolyte 
imbalances. 
¾ Intestinal injuries may not be apparent in the first few days of life.  Poor 
peristalsis and delayed gastric emptying are common; necrotizing 
enterocolitis occurs rarely. 
 
Sarnat & sarnat clinical stages is used to estimate the severity of 
asphyxial insult to infants more than 36 wks gestational age on an 
individual basis at the bed side. 
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Sarnat and Sarnat’s   Clinical stages of  Hypoxic Ischemic 
Encephalopathy 
 
 Stage 1 Stage 2 Stage 3 
Level of 
consciousness 
Hyperalert Lethargic or 
obtunded 
Stuporous 
Neuromuscular control 
Muscle tone Normal Mild hypotonia Flaccid 
Posture Mild distal 
flexion 
Strong distal flexion Intermittent 
decerebration 
Stretch reflexes Overactive Overactive Decreased or absent 
Segmental myoclonus Present Present Absent 
Complex Reflexes 
Suck Weak Weak or absent Absent 
Moro Strong; low 
threshold 
Weak; incomplete; 
high threshold 
Absent 
Oculovestibular Normal Overactive Weak or absent 
Tonic neck Slight Strong Absent 
Autonomic Function Generalised 
sympathetic 
Generalised 
parasympathetic 
Both systems 
depressed 
Pupils Mydriasis Miosis Variable; often 
unequal; poor light 
reflex 
Heart Rate Tachycardia Bradycardia Variable 
Bronchial and 
Salivary secretions 
Sparse Profuse Variable 
Gastrointestinal 
Motility 
Normal or 
decreased 
 
Increased ; diarrhea Variable 
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Seizures None Common ; focal or 
multifocal 
Uncommon (excluding 
decerebration) 
Electroencephalogram 
Findings 
Normal  
(awake) 
Early : low – 
voltage continuous 
delta and theta  
Later : periodic 
pattern (awake) 
Seizures : focal 
spike and wave. 
Early : periodic pattern 
with Isopotential 
phases  
Later : Totally 
isopotential 
Duration < 24 hrs 2-14 days Hours to weeks 
                        
LAB TESTS       
                                                                                  
1. Serum creatine kinase brain fraction CKBB at 4 and 10 hours of life  > 
15 IU was found to be associated with mortality or neurological 
sequelae. 
2. CKBB together with protein S – 100 ( > 8.5 µg/l)  & decreased cord 
blood PH is found to have high specificity & sensitivity in predicting 
moderate to severe encephalopathy 
 
EEG : 
 EEG with clinical signs may help in evaluating & classifying the 
severity of damage (eg. Seizure foci)  EEG should be obtained early in 
moderate to severe cases.  Background EEG activity is better indicator of 
prognosis than ictal patterns. 
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1. Generalised depression of background rythm & voltage are early 
findings. 
2. Burst suppression pattern is particularly  ominous. 
 
Cranial Ultrasound : 
 It provides quick assessment of brain lesions.  It reveals hemorrhages & 
periventricular changes and less well the extent of edema. 
 
CT  Scan : 
 It is more useful in assessing the degree of edema when performed early 
(2-4 days).  CT may not be useful in predicting sequelae in premature infants  
because of excess water & lower myelin content. 
 It is useful in demonstrating focal ischemic lesion. 
 
MRI : 
 MRI particularly with diffusion weighted images is the diagnostic 
modality of choice & is also prognostically useful 
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Prognosis of perinatal asphyxia : 
 Birth Asphyxia severe enough to damage the fetal brain irreversibly 
usually kills before / soon after birth (one fourth of cases).  The remainder 
however even those with seizures will be overwhelmingly normal. 
 
Outcome : 
1. Overall full term asphyxiated infants  have a mortality of 10 to 20% .  
The incidence of neurologic sequelae in survivors is 20 to 45 %. 
Approximately 40% of these are mild  and 60% are severe 
 
2. Analyzed according to Sarnat’s stages of severity virtually 100% of 
newborns with stage 1 have normal neurologic outcome 80% of 
those with stage 2 are normal neurologically & virtually all children 
with stage 3 either die ( one half) or develop major neurologic 
sequelae  ( Cerebral palsy, epilepsy, mental retardation) 
 
3. The risk of CP in asphyxiated newborns is elevated 5-10% versus 2 
per 1000 in general population. Data from national collaborative 
perinatal project 4 (U.S.) suggests  that perinatal factors of labour and 
delivery contribute little to mental retardation &seizure. 
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Indicators of Poor Outcome : 
Unfavourable signs : 
1. Severe prolonged asphyxia 
2. Sarnat stage 3  encephalopathy 
3. Seizures of early onset ( < 12 hrs) and that which are difficult to control. 
4. Elevated Intracranial pressure 
5. Persistence of abnormal neurologic signs at discharge ( > 1-2 wks) 
6. MRI showing abnormal signal intensities 
7. Elevated CKBB level 
8. Persistant oliguria for first 36 hrs of life 
9. Interictal background abnormalities in EEG (Burst suppression, 
isoelectric potential) 
10.Intraventricular  hemorrhage grade II or more in Ultrasound cranium 
     11.  Ischemia & infarction over parasagittal area 
 
Neurologic Sequelae : 
 The precise neurologic sequelae following asphyxia will reflect location, 
identity & extent of neuronal damage.  Cerebral palsy of various types, 
Epilepsy, Auditory & visual impairment are major sequelae.  Minor motor 
difficulties, ADHD, language & learning difficulties also occur. 
 During follow up detailed neurological & developmental examination 
should be conducted to identify early clinical markers of developmental delay. 
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DEVELOPMENTAL ASSESSMENT:                                   
 The importance of early diagnosis and treatment of children with 
developmental de-lay has emerged in recent years as a matter of growing 
concern  . Early identification of children with delayed development has 
important implications for their treatment and in preventing risks of future 
disabilities and secondary problems related to family dysfunction, peer 
difficulties, and school failure. 
 Developmental screening is a brief testing procedure designed to 
identify children who should be subjected for intensive diagnostic assessment.  
Screening refers to the detection of unsuspected deviations from normal 
development that would not otherwise be identified in routine pediatric 
practice.  The goal of screening is to identify, as early as possible, 
developmental disabilities in children at high risk so that a treatment or 
remediation can be initiated at an early age when it is most effective. 
 The three approaches to screening include informal, routine and 
focussed developmental screening. 
 
I. Informal screening is based on observing the child during a routine 
pediatric check up and asking parents about their concerns about 
child’s development. Upper limits of normalcy have been used as cut 
off points to help identify delay. 
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Such an approach is not a very sensitive way of screening as it is 
only useful for not missing major delays. 
 
Guidelines for Screening : 
1. Screening instruments should be 
a. Reliable and valid 
b. Culturally relevant 
c. Used only for their specified purpose 
2. Multiple sources of information should be used. 
3. Developmental screening should be done only by trained personnel. 
4. Screening should be on a recurrent and periodic basis. 
5. Family members should be part of the screening process. 
 
II. Routine formal screening entails systematic developmental screening 
of all children with the help of standardized screening instruments.  However, 
such an approach is highly time consuming.  In our country, as well as in other 
developing countries, with enormous populations, routine formal screening is 
neither feasible nor cost effective. 
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III. Focussed screening involves developmetal screening of the following 
groups of children. 
a) Children whose parents express developmental concerns or in 
whom teachers and physicians suspect problems. 
b) Newborns with condition that have known to have high risk for 
developmental delay. ex. Hypoxic ischemic encephalopathy. 
 
Developmental Screening Tests : 
 Several developmental screening tests are available for use in infants 
and children.  There are several well accepted criteria by which various tests 
are judged to be appropriate for use in screening programs.  It is recommended 
that screening test should be simple, brief, convenient to use, cover all areas of 
development, have adequate construct validity be applicable to a wide age 
range, and have referral criteria that are both specific and sensitive. 
 
 By far the most commonly used screening test is the Denver 
Development Screening Test (DDST).  The DDST is used to screen children 
from two weeks through 6 years of age in four developmental domains;  gross 
motor, fine motor adaptive, personal social and language skills. 
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Trivandrum Developmental Screening Chart (TDSC) 
 Commonly used revised DDST has 125 items and takes about 20-30 
min to perform by a trained individual. 
 TDSC is a modification of Baroda scale & it contains about 17 items. 
These items include testing the gross motor, fine motor, social & adaptive and 
language skills of the child.  Tests for vision & hearing are also included in it.  
They include tests to assess whether child holds head steady,  rolls from back 
to stomach,  raises self to sitting position, stands up by furniture,  walk with 
help,  walks alone, walk backwards, walk upstairs with help, social smile,  pat 
a cake,  throws ball, points to parts of doll (3 parts), transfer objects hand to 
hand, fine prehension pellet, says two words, eyes follow pen / pencil, turns 
head to sound of bell/ rattle etc appropriate to the age. 
 Following elicitation of history from the mother assessment is done 
using TDSC.   A line is a drawn over the corresponding vertical age line in the 
chart appropriate to the child’s age.  The left hand side of each horizontal dark 
line represents age at which 3% of children passed the items & right end 
represents 97%. 
 All the milestones to the left of the age line are tested.  Testing standards 
for few motor skills have been provided by Child Development Centre(CDC).  
A normal child would have achieved all the milestones to the left of the age 
line. 
 28
 A child who has not achieved one or more skills completely to the left of 
the age line is suspected to have developmental delay. Repeat testing may have 
to be done a few days later. 
 TDSC can be used for children from 0-24 months. It contains only 17 
items & is not time consuming (5-7 mins) and can be used in busy office 
practices.  It can be used by paraprofessionals also as it is simple to perform.  
It is only a screening test. Any delay has to be confirmed by proper & 
complete neurodevelopmental assessement. 
 
CDC Grading of Motor Milestones 
Head Holding : Completed 4 months 
Grade0 - No head holding at all 
I - Head erect & steady momentarily 
II - Dorsal suspension – lifts head along with body 
III - prone position - elevates on arms, lifting chest 
IV - Holds head steady while mother moves around 
V - Head balanced at all times 
 
Sitting : Completed 8 months 
Grade0 - Not sitting 
     I - Sits momentarily 
II - Sits for > 30 seconds leaning forward 
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III - Sits with back straight 
IV -    while sitting can turn around & manipulate a toy 
V - self rises to sit 
 
Standing  : Completed 12 months 
 0 - Not able to stand 
 I - holding furniture momentarily 
 II - takes few steps with both hands held 
 III - stands without support, stands alone with legs apart 
 IV - stands himself up 
 V - Stands without support to take a few steps. 
 
Assessment : 
 0, I, II - Abnormal for that age 
 III, IV, V - Normal 
 
 
 
 
 
 
 
 30
LITERATURE REVIEW 
1. Figueras – Aloy J et al,  the study conducted to find out the incidence 
of neurodevelopmental delay showed about 11.2 % of babies with 
hypoxic ischemic encephalopathy were found to have neurological 
impairment. 
 
2. Birth Asphyxia – Incidence, clinical course and outcome in a 
Swedish population. Acta. Pediatrics, 1995,  
Neurological abnormality of 10% was observed among the 65 babies 
who had HIE. 
 
3. Robertson et al in 1993. The outcome in mild and severe form of 
HIE is predictable but in moderate form, it is uncertain.  However the 
babies had variable degree of deficit. 
 
4. Freeman J.M.et al., 25% of the babies with HIE were found to be 
neurologically abnormal on follow up. 
 
5. Neonatology division children’s hospital of Pittsburg.  Out of the 65 
babies with asphyxia who were followed up for 4.8 years 35.4% of 
babies had neurological impairment. 
 31
6. Ellis M. et al., Outcome at 1 year of neonatal encephalopathy in 
Kathmandu, Nepal.  By 1 year ofage,45 (44%) of the infants with 
Neonatal encephalopathy had died, 18 (18%) had severe impairments 
and two(2%) had minor impairments. Of the 18 children with major 
impairment, 14(78%) had spastic tetraplegic cerebral palsy and eight 
(44%) had multiple impairments. 
 
7. Glenny Dixon et al,  Early developmental outcomes after newborn 
encephalopathy.  Overall 39% of patients had a poor outcome as 
defined by death, cerebral palsy, or a significant degree of 
developmental delay.  62% of those with severe encephalopathy had 
a poor outcome compared with 25% of those with moderate 
encephalopathy.  Patients with a history of seizures were 3 times 
more likely to develop cerebral palsy than patients without.  Overall, 
28 (10.1%) of patients had cerebral palsy. 
 
8. Funayama CA et al, Hypoxic – ischemic encephalopathy in new born 
infants.  Acute period and outcome. 
The HIE I group had no motor sequelae.  In HIE II group 34.5% 
showed cerebral palsy and 17.7% neuromotor retardation.  Epilepsy 
occurred in 17.5% of cases with HIE grade II, only among those with 
neuromotor sequelae. 
 32
9. Asakura H. et al, Perinatal risk factors related to neurologic 
outcomes of term new borns with asphyxia at birth : a prospective 
study. Of the 152 newborns in 1 year prospective follow  up. The 
incidence of a poor neurologic outcome was 13.8% among the 
subject.  The risk of a poor outcome was increased by 13 fold in 
neonates with adverse neurological signs and 31 fold in those with 
hypoxic ischemic encephalopathy. 
 
10. Pierrat V. et al, Prevalence, causes and outcome at 2 years of age of 
newborn encephalopathy :  Population based study.   90 neonates 
with moderate or severe newborn encephalopathy were followed up 
for 2 years.  14 infants had a poor outcome. 
 
11. Zhou.XJ., et al., Follow up study of mental development in high risk  
children.  There was significant correlation between developmental 
assessment at 6 and 12 months and mental development at 7years.  
The evaluation of development at 12 months is of predictive value 
for long term outcome.  
 
12. Zupan et al., Neurological prognosis of term infants with perinatal 
asphyxia.  Mild encephalopathies have constantly a good prognosis.  
 33
Moderate and severe encephalopathies are associated with poor 
outcome (death or severe handicap) in 25% to 100% of cases. 
 
13. Oswyn G, et al Perinatal asphyxia at Port Moresby General Hospital 
: a study of incidence, risk factors and outcome.  All 34 of the babies 
with grade 3 hypoxic ischemic encephalopathy (HIE) either died (30) 
or had serious neurological impairment. 
 
14. Sorenson LC et al, Neonatal asphyxia – prognosis based on clinical 
findings during delivery and the first day of life.  Neither 
complications of pregnancy, gestational age, the sex of the infant, 
passage of meconium  before delivery, abnormal fetal heart rate nor 
birth weight seemed to have any interrelationship with outcome.   
The best predictor of outcome after intrapartum asphyxia was the 
severity of postasphyxial encephalopathy. The Apgar score was more 
depressed among the infants with poor outcome. 
 
15. Mercuri E., et al, Head growth in infants with hypoxic – ischemic 
encephalopathy : correlation with neonatal magnetic resonance 
imaging.  At 12 months, microcephaly was present in 48% of the 
infants with HIE, compared with 3% of the controls. Suboptimal 
head growth was documented in 53% of the infants with HIE, 
 34
compared with 3%of the controls.  Suboptimal head growth 
predicted abnormal neurodevelopmental outcome with a sensitivity 
of 79% and a specificity of 78%. 
 
16. Leuthner SR et al :  Low Apgar score & definition of birth Asphyxia.                     
Non reassuring fetal heart rate pattern, prolonged labour, meconium 
stained fluid , low 1 min apgar score & mild to moderate acidemia 
have no predictive value for long term neurological injury without 
encephalopathy or seizures. 
 
17. Karin B et al, Apgar scores as predictor of chronic Neurologic 
disability.  Low apgar scores were risk for cerebral palsy. But 55% of 
children with cerebral palsy had 1 min score of 7-10 & 73% with CP 
had 5 min score of 7-10.  About 12% of 99 babies with Apgar score 
of 0-3 at  > 10 min had CP.  11% of them had mental retardation & 
about 50% of them had seizures. 8 of these had other significant 
disabilities. 
 
18. Meharban Singh :  Care of the Newborn 6th edition.  HIE is a better 
predictor of subsequent handicap than poor Apgar scores. EEG 
abnormalities , intraventricular hemorrhage > grade II on 
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Neurosonogram & CT Brain abnormalities are associated with 
adverse outcome. 
19. John.P.Cloherty :  Manual of Neonatal Care : 5th edition Neurologic 
sequelae in survivors of HIE is 20 to 45%.  Incidence is greater with 
severe encephalopathy. Perinatal factors of labour & delivery 
contribute little to the incidence of mental retardation, seizures & 
cerebral palsy.  Sarnat stage 3 encephalopathy, early onset seizures 
(<12 hrs), abnormal extended apgar score are some indications of 
poor outcome. 
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AIMS  & OBJECTIVES 
 
Aims of the study are 
1. To study the incidence and types of neurologic sequelae at one year 
of age in babies admitted with neonatal hypoxic ischemic 
encephalopathy in the newborn ward in Institute of child health  & 
research centre, Government Rajaji Hospital, Madurai.   
2. To study the correlation of severity of Hypoxic ischemic 
encephalopathy to neurodevelopmental outcome. 
 
3. To study the perinatal factors affecting neurodevelopmental outcome 
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METHODOLOGY 
 
Study Design : 
 It is a prospective Analytical cohort study 
 
Study Population: 
 The babies born between april 2004 and july 2004 & admitted with 
Hypoxic ischemic encephalopathy in newborn ward in Institute of child health 
and research centre madurai were included in the study. 
 
Study Duration : 
 The babies were followed up for upto 1 year of age (from April 2004 to 
July 2005.) 
 
Sampling : 
 Simple Random Sampling 
 
Sample Size : 
 For an alpha error of 0.05 and power of 0.8 taking into account mortality 
& drop rate a total of 100 babies were included in the study. 
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Inclusion criteria : 
1. Term Newborn babies weighing > 2 kg admitted in Newborn ward 
ICH & RC Madurai 
2. H/o birth asphyxia defined by 
a. Apgar score of < 7 at 5 min and /or 
b. Need for positive pressure ventilation > 1min after birth 
3. Presence of features of hypoxic ischemic encephalopathy : 
a.Altered consciousness 
b. Abnormal tone & reflexes 
c.  Seizures 
4. Thick meconium stained babies with HIE 
 
Exclusion Criteria : 
1. Babies with HIE who died during hospital stay 
2. Depression from maternal anesthesia / analgesia 
3. Babies weighing  < 2 kg 
4. Premature babies 
5. Babies with cyanotic congenital heart disease 
6. Babies with CNS malformation / other severe congenital 
malformation 
7. Babies with sepsis / meningitis 
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Methodology : 
 After admission in the newborn ward the babies to be studied were 
registered. Detailed antenatal and birth history was taken & anthro pometry 
was done.  By clinical neurological examination babies were grouped by 
Sarnat & Sarnat staging of HIE. Clinical course during hospitalization was 
studied.   All the above details were recorded in a standard proforma 
(Annexure 2) 
 Babies who died during hospital stay due to complications of HIE were  
excluded from the study.  Necessary investigation like EEG, USG cranium and 
CT scan was done. 
 
 After discharge the babies who survived the hospitalization were 
followed up at well baby clinic in ICH & RC upto the age of one year. The 
follow up was done every 3 months at 3,6,9 and 12 months of age. 
 
 At each follow up visit mothers were given a questionnaire regarding 
babies milestones.   Neuro developmental assessment of babies was done 
using Trivandrum developmental screening chart. (Annexure1).                     
Babies were assessed for achieved milestones at each follow up. Babies who 
did not achieve milestones completely to left of age line on TDSC were 
considered to have developmental delay. A repeat testing was done 2 weeks 
later.  
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Clinical Neurological Examination : 
 Complete neurological examination of babies was done.  Special 
emphasis was given on 
1. Presence of cranial nerve palsies 
2. Strabismus 
3. Examination for hypertonia / hypotonia by scarf sign, adductor 
angle and passive movements of limbs. 
4. Examination for weakness of muscle groups 
5. Deep Tendon Reflexes were elicited for presence of hyperreflexia 
Measurement of Head circumference was done at each follow up. 
Clinical visual and auditory evaluation was done at every visit. Babies 
with abnormalities were subjected to thorough ophthalmic examination and 
otoacoustic emission testing.   
Neonatal  reflexes : 
 Special emphasis was given to elicitation of 
1) Moro reflex 
2) Grasp reflex 
3) Asymmetric tonic neck reflex 
Children were observed for the persistence or asymmetry of these 
reflexes. 
 Necessary investigation  & appropriate treatment was also given to these 
babies during follow up period. 
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OBSERVATION & ANALYSIS 
 
 A total number of 100 babies were enrolled for the study & were 
followed up for 1 year. 
Hospital admission data for 4 months April to July 2004. 
TABLE - 1 
Total no. of live births  6000 
Total no. of admission in newborn ward 560 
Total no. of cases of birth asphyxia 132 
 
Out of 132 babies admitted with birth asphyxia excluding babies with 
prematurity, Birth weight  < 2 kg etc,  100 babies were registered & followed 
up in the well baby clinic up to the age of one year & the neurodevelopmental 
status was evaluated periodically at the interval of three months. 
 
 Statistical Analysis : 
Computer analysis of data utilizing the software – Epidemiological 
Information Package – 2002 ( Epi Info 2002 ) – developed by the Centers for 
Disease Control and Prevention, Atlanta for World Health Organization. 
Mean, Standard deviation and ‘p’ values were calculated using this 
package. Chi square test was used to calculate ‘p’ value. 
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ANALYSIS OF OUTCOME MEASURES  
Neuro developmental outcome : 
 100 babies were followed up at the well baby clinic upto the age of 1 
year and their neurodevelopmental status was evaluated periodically at 
intervals of 3 months using. 
1. Clinical Neurological examination including testing of vision & hearing 
2. Developmental Screening using Trivandrum Developmental  
Screening Chart (Annexure 1) 
Developmental delay in the study was defined by failure to achieve milestones 
appropriate for the age based on TDSC. 
 
Basic statistics 
TABLE - 2 
HIE I II III Total 
Enrolled 39 48 13 100 
Completed follow up 28 42 11 81 
Drop out 11 6 2 19 
Drop out  % 28 12.5 15.5 19 
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Neurodevelopmental Status : 
At 3 months of Age 
TABLE - 3 
Neurodevelopmental status No. % 
Normal 55 55 
Abnormal 32 32 
Drop out 13 13 
  
 During the first evaluation at 3 months of age, 55% of babies were 
normal & 32% were abnormal.  13 babies did not come for follow up. Dropout 
rate was 13%. 
 
At  6 months : 
TABLE - 4 
Neurodevelopmental status No. % 
Normal 64 64 
Abnormal 21 21 
Drop out 15 15 
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 9 babies who showed developmental delay at 3 months were found to be 
normal during next follow up visit.  2 more babies in addition to earlier 13 
babies did not come for follow up. 
At 9 months : 
TABLE - 5 
Neurodevelopmental status No. % 
Normal 63 63 
Abnormal 19 19 
Drop out 18 18 
 2 babies who were abnormal at 6 months were found to be normal at 9 
months. 3 more babies did not come for followup. All the babies who were 
normal at 6 months continued to be normal. 
 
 
At 12 months : 
TABLE - 6 
Neurodevelopmental status No. % 
Normal 62 62 
Abnormal 19 19 
Drop out 19 19 
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At 1 yr of age,  62 babies were normal (62%),  19 babies were abnormal and a 
total of  19 babies had not come for follow up. 
 
 
Developmental Delay - Breakup Age wise  
TABLE - 7 
Months I II III Total 
3 4 16 12 32 
6 1 9 11 21 
9 0 8 11 19 
12 0 8 11 19 
 
 Babies who were found to be abnormal at 9 months persisted to have 
developmental delay at 1 year. Babies who were normal at  
3 to 6 months, remained normal thereafter. 
Incidence of developmental delay -  at 1 year of age. 
TABLE - 8 
Babies enrolled Completed 
Follow up 
Developmental 
delay 
% 
100 81 19 23.4 
 
Out of the 100 babies enrolled for the study about 19% dropped out by 
the end of 1 year.  81 out of the 100 babies came for regular follow up for the 
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study period of one year.  By the end of 1 year 19 babies out of the 81 were 
observed to have developmental delay based on Trivandrum Developmental 
Screening chart.  That is about 23.4 % of children with Hypoxic ischemic 
encephalopathy were found to be abnormal at 1 year of age. 
 
Incidence of developmental delay in relation to  HIE  stages 
TABLE - 9 
 
 Follow up Developmental 
delay 
% 
I 28 0 0 
II 42 8 19 
III 11 11 100 
 
 Out of the 28 babies with HIE stage 1 who completed follow up none 
had any developmental delay. That is Developmental delay in HIE stage 1 was 
zero percentage. 
 Out of the 42 babies HIE stage II , 8 babies were found to be abnormal 
at 1 year of age. That is 19% of the babies with HIE stage II had 
developmental delay. 
 And  all of the 11 babies with HIE stage III (100%) had developmental 
delay. 
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Other Disabilities : 
Motor Disabilities at 1 year of age 
TABLE - 10 
 I II III Total 
Spastic quadriparesis 0 2 3 5 
Generalised Hypotonia 0 0 1 1 
  Total  6 
Motor disabilities were found in 6 out of 81 babies, ie. About 7.5%. 
Spasticity was the most common abnormality detected (83%) and it was found 
only in HIE stage III and Stage II. 
Visual Disabilities at 1 yr of age 
TABLE - 11 
HIE Stage I II III Total 
Convergent squint 0 5 3 8 
Squint with Amblyopia 0 1 0 1 
Cortical blindness 0 1 1 2 
  Total  11 
 
About 13.5% of children with HIE were found to have visual disability 
and most common was convergent squint.  The disabilities were more common 
in HIE Stage II and Stage III.  Cortical blindness was found in 2 out of 11  
children (18%). 
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Hearing Defects  
 Babies who where found to have hearing defects by clinical examination 
otoacoustic emission testing was done.  Out of the 5 babies who were found to 
have hearing defects by clinical examination 2  were found to have deafness 
by  otoacoustic emission testing.  
 HIE  Stage II - 1 
 HIE Stage III - 1 
Seizures Disorder 
TABLE - 12 
HIE Stages I II III Total 
Generalised tonic clonic 0 2 0 2 
Myoclonic 0 1 0 1 
Total 3 
 
 About 3 children out  of 81 persisted to have recurrent 
convulsions.(3.7%)  Convulsions in all 3 cases needed atleast 2 
anticonvulsants for effective control. 
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Microcephaly  
 Correlation of Head circumference at 1 year of age with HIE Staging 
TABLE - 13 
HIE Stage Head Circumference 
in cm I II III 
Mean 43.75 41.15 38.7 
Standard Deviation 
(S.D) 
0.68 1.72 0.75 
 
Mean Head circumference of babies with HIE stage III was significantly lower 
compared to that of HIE stage II & stage I.  HIE stage I babies had a mean 
head circumference in the normal range 
Correlation  of Head circumference with HIE stages 
TABLE - 14 
HIE Stage Actual 
difference of 
Mean 
S.E.(d) 
Standard Error 
of difference 
between means
HIE I & II 2.6 0.28 
HIE I  & III 5.05 0.26 
HIE II  &  III 2.45 0.34 
 
Comparing the head circumference of babies with HIE I , HIE II,  & HIE –III  
the actual difference of mean was more than twice the standard error of 
difference between Means (S.E.(d)) 
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PERINATAL RISK FACTORS & OUTCOME  
  To study impact of the perinatal risk factors on neurodevelopmental 
outcome. 
MATERNAL FACTORS : 
1.  Antenatal Immunisation & Antenatal check up : 
 82 of 100 mothers (82%) had two doses of tetanus toxoid & atleast two 
antenatal checks. 18 out of 100 mothers did not have even one antenatal check 
up and they were un immunized. 
 
2.  Parity :   
TABLE - 15  
 
Total no. of Pregnancies Numbers % 
One 62 62 
Two 26 26 
Three 8 8 
Four 2 2 
>  Four 2 2 
  
Out of the 100 babies, born with birth asphyxia about 62 out of 100 mothers 
were primi (62%). & only 10 were above second gravida.  
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Correlation of Parity with developmental delay 
TABLE - 16 
 
Developmental 
Delay 
Parity 
Yes No 
Relative risk P value 
Primi 12 38 
> Two 7 24 
 
0.82 
 
> 0.05 
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3. Maternal Illness : 
TABLE - 17 
Maternal Illness Numbers % 
APH 3 3 
PIH 22 22 
Cardiovascular disease 2 2 
Diabetes mellitus 1 1 
Antenatal infections 4 4 
Total 32 32 
 
 Out of 100 mothers 32 of them (32%) had some form illness 
complicating pregnancy. In this study preg`nancy induced hypertension (PIH) 
was the most frequent maternal illness associated with birth asphyxia. 
 
Correlation of Maternal Illness with developmental delay. 
TABLE - 18 
Developmental Delay  
Maternal Illness  
Yes 
 
No 
 
Relative Risk 
 
P value 
Present 9 16 
Absent 10 46 
 
2.11 
 
>0.05 
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4. Mode of delivery : 
TABLE - 19 
 Mode of delivery Numbers % 
Labour natural 79 79 
Forceps 9 9 
LSCS 12 12 
Vacuum 0 0 
 
 79 out of 100 mothers (79%) delivered Vaginally, 9 deliveries required 
forceps application (9%) & 12 babies were delivered by Caesarean section 
(12%).  Vacuum application is not practiced in our institution. 
 
Correlation of Mode of delivery with developmental delay 
TABLE - 20 
Developmental Delay  
Mode of Delivery  
Yes 
 
No 
 
Relative Risk 
 
P value 
Labour Natural 15 46 
Others 4 16 
 
1.22 
 
>0.05 
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5. Meconium stained liquor : 
 Meconium stained liquor was documented in 22 out of 100 mothers 
(22%) 
Correlation of Meconium stained liquor with developmental delay 
TABLE - 21 
Developmental Delay Meconium stained 
Liquor  
Yes 
 
No 
 
Relative Risk 
 
P value 
Present 3 11 
Absent 16 51 
 
0.89 
 
> 0.05 
 
 
6. Mode of Presentation : 
Majority of the deliveries were by vertex presentation 89%.  Breech 
presentation was observed in only  11% of the babies. 
 
Correlation of Mode of presentation with developmental delay 
TABLE - 22 
Developmental Delay Mode of 
presentation Yes No 
 
Relative Risk 
 
P value 
Vertex 16 58 
Breech 3 4 
 
0.50 
 
> 0.05 
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NEONATAL FACTORS : 
1. Sex 
TABLE -23 
Sex No. % 
Male 62 62% 
Female 38 38% 
 
 62 out of the 100 babies with birth asphyxia were males – 62% and 38% 
were females.  Male to Female ratio is  1.6  :  1 
 
Correlation of Sex with developmental delay 
TABLE - 24 
Developmental Delay Sex 
Yes No 
Relative 
Risk 
 
P value 
Male 12 40 0.95 >0.05 
Female 7 22   
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2.Birth Weight : 
TABLE - 25 
Birth Weight (wt in gms) Numbers % 
2000 – 2500 37 37 
2500 – 3000 49 49 
>  3000 14 14 
  
Those babies having birth weight below 2000 gms were excluded form 
the study.  37% of babies were between 2 – 2.5 kgs, 49% between 2.5 & 3.0 kg  
& 14% above 3.0 kg 
 
Correlation of Birth weight with developmental delay 
TABLE - 26 
Developmental Delay BirthWeight 
Yes No 
Relative 
Risk 
 
P value 
< 2.5 kg 7 25 
> 2.5 kg 12 37 
 
0.89 
 
>0.05 
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3. Time of first cry  : 
TABLE - 27 
 Time of First cry Numbers % 
<  5 min 27 27 
5 – 10 min 25 25 
10 – 20 min 21 21 
20 min – 1 hr 19 19 
> 1 hr 8 8 
 
About 27 % of babies cried within 5min, 25% of babies between 5-10 
min, 22% of babies cried between 10-20 min. and 20% of babies cried 
between 20 min. to 1 hr.  About 8 % of babies cried after 1 hr or later. Thus 
about 27 % of babies had only mild degree of asphyxia. 
 
Correlation of Time of first cry with developmental delay 
TABLE - 28 
Developmental Delay Time of first cry 
Yes No 
 
Relative Risk 
 
P value 
> 20 min 10 14 
< 20 min 9 48 
 
4.52 
 
<0.001 
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4. Apgar Score at 5min of birth 
TABLE - 29 
Apgar Score No. % 
0 – 3 38 38 
4 – 7 62 62 
 
 38 out of the 100 babies were found to have an apgar score of less than 
or equal to 3 consistent with significant asphyxia 
 
 
Correlation of Apgar Score  at 5 min with developmental delay 
TABLE - 30 
Developmental Delay Apgar score at 
 5 min Yes No 
 
Relative Risk 
 
P value 
0 – 3  9 26 
4 – 7 10 36 
 
1.18 
 
>0.05 
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5.  Apgar Score at 20 min. 
TABLE - 31 
Apgar Score No. % 
0 – 3 22 22 
4 – 7 78 78 
 
 Out of the 38 babies who had apgar score of less than or equal to 3 about 
16 babies had a better apgar score of more than 3 at 20 min. only 22% of the 
babies had apgar score of less than 4 at 20 min. 
 
 
Correlation of Apgar score at 20 min with developmental delay 
TABLE - 32 
Developmental Delay Apgar score at  
20 min Yes No 
 
Relative Risk 
 
P value 
0 – 3 11 18 
4 – 7 8 44 
 
2.46 
 
< 0.001 
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6. Resuscitation at 1 min of birth : 
TABLE - 33 
 Resuscitation at 1 min No. % 
Routine 38 38 
PPV at 1 min 62 62 
 62 out of 100 babies required positive pressure ventilation either by bag 
mask or endotracheal tube (62%)at 1 min after birth. 
 
PPV  at 1 min                                     TABLE - 34 
 Resuscitation No. % 
Bag mask ventilation 58 93.5 
Endo tracheal intubation and ventilation 4 6.5 
  About 38% of babies required only routine resuscitation & had 
mild asphyxia.62% of the babies  required positive pressure ventilation at 1 
min after birth. 93.5% of these babies required bag and mask ventilation      
and about 6.5 % of these babies required intubation & ventilation. 
Correlation of Resuscitation at 1 min  with developmental delay 
TABLE - 35 
Developmental 
Delay 
 
Resuscitation at 1 
min 
Yes No 
 
Relative Risk 
 
P value 
PPV 14 37 
Routine 5 25 
 
1.21 
 
> 0.05 
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7. Sarnat & Sarnat Staging : 
 Babies who developed hypoxic ischemic encephalopathy as evidenced 
by altered consciousness, abnormality of tone and presence of convulsions 
were classified into 3 groups based on Sarnat and Sarnat clinical staging.  
 
39  babies out of 100 developed hypoxic ischemic encephalopathy - 
Sarnat & Sarnat Stage I.  48%  of babies developed HIE Stage II & 13% of 
babies developed HIE  stage III  
 
Breakup of cases according to HIE stages 
TABLE - 36 
HIE Stage No. % 
I 39 39 
II 48 48 
III 13 13 
  
 Babies with severe encephalopathy – HIE stage III were found to be less 
in number compare to HIE stage I and HIE stage II 
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Correlation of Sarnat & Sarnat Staging with developmental delay 
 
HIE stage I with HIE Stage II 
TABLE - 37 
Developmental DelaySarnat Stage 
Yes No 
 
Relative Risk 
 
P value 
I 0 28 
II 8 34 
 
α  
(Infinite) 
 
<0.01 
 
HIE stage I with HIE Stage III 
TABLE - 38 
Developmental DelaySarnat Stage 
Yes No 
 
Relative Risk 
 
P value 
I 0 28 
III 11 0 
 
α 
(Infinite) 
 
<0.001 
 
HIE stage II with HIE Stage III 
TABLE - 39 
Developmental Delay Sarnat Stage 
Yes No 
 
Relative Risk 
 
P value 
II 8 34 5.25 <0.001 
III 11 0   
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8.  Duration of hospital Stay: 
TABLE - 40 
Duration of hospital Stay No. % 
<  10  days 71 71 
> 10 days 29 29 
 
Duration of hospital stay of babies was arbitrarily classified into less 
than or equal to 10 days and more than 10 days.  About 71% of babies were 
discharged within 10 days and 29% of the babies after 10 days. 
 
 
Correlation of duration of hospital stay with developmental delay 
TABLE - 41 
 
Developmental Delay Duration of 
Hospital Stay Yes No 
 
Relative Risk 
 
P value 
> 10 days 12 13 
< 10 days 7 49 
 
3.84 
 
< 0.001 
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9.  Convulsions :  
TABLE - 42 
Convulsions No. % 
Present 51 51 
Absent 49 49 
 
 About 51% of babies had atleast 1 episode of convulsions. 48 out of 51 
babies with convulsions belonged to HIE Stage II and 3 babies belonged to 
HIE Stage III.out of the 51 babies only 43 completed follow up 
 
 
Correlation of Convulsions with developmental delay 
TABLE - 43 
Developmental 
Delay 
 
Convulsions 
Yes No 
 
Relative Risk 
 
P value 
Present 15 28 
Absent 4 34 
 
3.31 
 
>0.05 
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10.  Time of onset of convulsions. 
N = 51 
TABLE - 44 
Time of onset No. % 
< 12 22 22 
12 – 24 18 18 
>  24 11 11 
 
 22 out of the 51 babies developed convulsions within 12 hrs of birth 
(43%) and remaining 29 babies had developed convulsions after 12 hrs (57%). 
 
Correlation of Time of onset of convulsion with developmental delay 
TABLE - 45 
Developmental Delay Time of onset of 
convulsion Yes No 
 
Relative Risk 
 
P value 
<  12 hrs 10 8 
> 12 hrs 5 20 
 
2.77 
 
< 0.05 
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INVESTIGATIONS : 
11.  Ultra sound cranium 
TABLE - 46 
USG cranium – Result No. % 
Normal 92 92 
Abnormal 8 8 
 
 USG cranium was taken in most babies in the first week.  Few babies 
whose general condition was poor neurosonogram was done before discharge. 
About 92% of the babies with HIE had normal Neurosonogram findings. 
About 8% had abnormalities. 
 
 Out of 8 babies with abnormal neurogram 6 had cerebral edema, 1 had 
intraventricular hemorrhage & 1 had altered periventricular echogenicity. 
 
Correlation of Ultra sound Cranium with developmental delay 
TABLE - 47 
Developmental Delay Ultra sound 
Cranium Yes No 
 
Relative Risk 
 
P value 
Abnormal 6 2 
Normal 13 60 
 
4.21 
 
< 0.001 
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12.  Electroencephalogram  :   
TABLE - 48 
EEG No. % 
Normal Study 23 38.5 
Abnormal record 37 61.5 
 
 EEG could be done only for 60 of the 100 babies. These included all 
babies in HIE stage II & 12 babies in HIE stage III 
 Out of the 60 babies 23 had a normal EEG ( 38.5%) &37 babies had 
abnormal EEG record (61.5%) 
Types of abnormalities in EEG : 
1. Poorly formed (low voltage) background waves in delta range.  No 
abnormal discharge. Diffuse cerebral dysfunction. 
2. Diffuse slowing with back ground beta to delta waves. Sharp wave 
discharges + 
Correlation of Electroencephalogram with developmental delay 
TABLE - 49 
Developmental Delay EEG 
Yes No 
 
Relative Risk 
 
P value 
Abnormal 11 25 
Normal 5 18 
 
1.40 
 
>0.05 
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DISCUSSION 
 
 Birth Asphyxia and the consequent hypoxic ischemic encephalopathy 
are the common clinical problems encountered in the newborn ward. 23.5 % of 
the admission in the new born ward of Institute of Child Health and Research 
Centre, Madurai are birth asphyxiated babies. 
 
 Out of 100 babies followed up neurodevelopmental evaluation was 
completed in 81 babies (81%) upto one year of age.  19 babies did not 
complete the follow up. 
 
Incidence of neurologic sequelae: 
19 out of 81 babies i.e 23.4% were neurodevelopmentally abnormal at 
one year of age. In a similar study conducted  by Asakura . H et al 33 showed 
13.8 % children with HIE had poor neurologic outcome.    
 
 The incidence of neurologic sequelae was found to be 14% in babies 
with HIE (Robertson C Finer) 10.  Similar results were obtained in a study by 
Thornberg E et al (Acta Pediatrica 1995) 15 
 
The higher incidence of neurological impairment observed in present 
study may be due to high incidence of birth asphyxia in our community and 
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also due to apparently normal babies (HIE stage I) not completing follow up. 
Also since Govt. Rajaji Hospital, Madurai is a tertiary care centre more 
number of complicated (Obstetric) cases are referred. The present study 
correlates with the observation that about 25-30% of babies are found to have 
permanent sequelae following HIE ( Nelson et al) 30 
 
Severity : 
 No baby with HIE Stage I  had developmental delay and all babies with 
HIE Stage III had developmental delay. The incidence of sequelae in moderate 
HIE was found to be about 19% which is slightly lower than that resulted in 
the study of Robertson C Finer et al (24%).10   
 
Types of delay : 
 Motor disabilities occurred in about 7.5% of all children with HIE. That 
is 31.5% of children with developmental delay (by TDSC) had motor 
disabilities. The risk was highest in HIE III (36%). Spastic quadriparesis was 
the most common abnormality found (83%). 
 
Visual disabilities : 
 Visual disabilities occurred in about 11 children (13.5% of asphyxiated 
children).  Strabismus was most common (72.0%) but was without visual 
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impairment in most children.  Cortical blindness with visual loss was present 
in 2 out of 11 patients. (18%) 
 
Hearing deficits : 
 Hearing deficits occurred in minority of asphyxiated children (2.5%). 
Early detection by otoacoustic emission testing helped in early referral for 
intervention.   
 
Seizure disorder : 
 Seizure disorder with recurrent convulsions in infancy was noted in 3 
children.  All were from HIE stage II encephalopathy (3.7%). 
 
Microcephaly : 
 Mean Head circumference was comparatively lower in children with 
HIE II & III compared to HIE I.  Children with significantly less optimal head 
growth had development delay.  Head circumference was normal in all 
children with normal neurological status. Similar results were obtained in 
study relating HIE to head  growth (Pediatrics 2000)24 
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RISK FACTORS : 
The factors significantly associated with neurodevelopmental deficit 
were HIE stage II, HIE stage III, delayed onset of first cry for more than 20 
minutes, Low apgar score at 20 min. presence of convulsions,  early onset of 
convulsions (< 12hrs),  duration of hospital stay for more than 10 days and 
abnormal Ultra sound cranium.  
These findings correlate well with other studies. 
 
Sarnat & Sarnat HIE staging : 
HIE stages showed marked correlation with neurodevelopmental deficit.  
None of the babies who had HIE stage I during neonatal period developed 
neurodevelopmental deficit.  But HIE stage II and stage III were significantly 
associated with neurodevelopmental deficit.  8 of the 48 babies who were in 
Sarnat and Sarnat stage II and all the 11 babies with Sarnat and Sarnat stage III 
had neurodevelopmental deficit at one year. 
 
In one study conducted in  Swedish population 15 the observation made 
was similar, that is the neurodevelopmental outcome correlated well with the 
severity of HIE. 
 Robertson et al in 199321 in his  study concluded that the outcome in 
mild and severe form of HIE is predictable but in moderate form, it is 
uncertain.  However the babies had variable degree of deficit. 
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Delayed onset of First Cry : 
The incidence of neurologic of sequelae was greater with delayed first 
cry >20 min (p <0.001) 
Apgar Score : 
 The incidence of developmental delay correlated well with Apgar score 
at 20 min. (p < 0.001) in this study. This correlates well with study by Nelson 
et al 32 that incidence of cerebral palsy increased with presence of low Apgar 
scores (1% at 5 min to 57% at 20 min) 
 
Convulsions : 
 In our study, presence of convulsions and early onset of convulsions     
< 12 hrs was associated with increased risk of developmental delay(p<0.001).   
This correlates with study done by Thornberg et al 8 which showed 
seizures increased risk of sequelae by 2-5 fold.  67% had died or developed 
sequelae. Early onset of seizures increases risk of adverse outcome (75% with 
seizures at < 4 hrs had developmental delay.)  
 
Duration of Hospital stay :  
Hospital stay (persistent neurological abnormality) of more than 10days 
was associated with greater risk of neurologic sequelae in our study  
The study by Scott H et al 1976 showed that   74% of asphyxiated infants who 
were normal neurologically by 2 weeks had no abnormal neurologic sequelae  
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EEG : 
30.5% with abnormal record developed neurologic sequelae. but this 
was not statistically significant (p>0.05) 
 Children with Normal / maturally delayed interictal EEG patterns have 
86% normal development. Mild depression or normal background was 
associated with  normal outcome (Volpe) 8.   
Only markedly abnormal record predicted subsequent morbidity or 
mortality( Clancy R et al). 8 
 
USG cranium : 
 6 out of 8 children with abnormal findings on ultra sound cranium had 
developmental delay (75%).(p < 0.001) . 
8 out of 9 infants with normal scan had normal outcome (Siegel MJ.  
HIE in terms infants).  
The result correlates well with other studies.  (Neur Croat 1992) 19 
Other Perinatal factors : 
 Other factors like maternal, illness, meconium stained liquor, mode of 
presentation, birth weight,  mode of delivery, sex, apgar score at 5 min, parity 
and  resuscitation at one minute were not significantly associated with 
neurodevelopmental deficit. 
 This is similar to this results obtained in studies relating to prognostic 
implication of perinatal factors. (J.Obstet 2000) 25 
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Developmental Screening : 
In this study, an attempt was made to find out the earliest time of 
assessment which can predict neurodevelopmental abnormality.  Although 
neurodevelopmental assessment at the age of 3 months was able to detect 
neurodevelopmental delay significant proportion of them became normal as 
child grew older.  
It was also observed that none of babies found to be abnormal at the age 
of 9 months became normal at the of 1 year. But those babies found to be 
normal in the assessment at 6 months persisted as normal till end.   
Hence it is inferred from this study that assessment at the age of 6 
months confirms normal neurodevelopmental status and assessment at the age 
of 9 months predicts abnormal neurodevelopmental outcome. However, these 
high risk babies must be followed up for longer period of time to detect subtle 
abnormalities which may appear later as the child grows older.  It is essential 
that any deviation from normal neurodevelopmental should be detected early 
so that early interventional measures can be initiated as early as possible. 
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CONCLUSION 
 
1. In this study out of 81 babies  who completed follow up, 23.4% 
showed neurodevelopmental deficits. 
2. The types of neurological sequelae found in HIE apart from delayed 
milestones were spastic cerebral palsy, hearing loss, visual 
impairment, epilepsy, and microcephaly. 
3. The  risk factors for neurodevelopmental deficit observed in this 
study are sarnat and sarnat HIE stage III , sarnat and sarnat HIE stage 
II , presence of convulsions, early onset convulsions of < 12 hrs, 
delayed first cry for more than 20 minutes duration of hospital stay > 
10 days and abnormal USG cranium. 
4. It is inferred from this study that the earliest age to detect definite 
neurodevelopmental abnormality is 9 months and the earliest age for 
predicting normal neurodevelopment is 6 months. 
5. Approximately ¼ of the survivors developed neurodevelopmental 
deficit at one year.  This emphasizes the need for early detection and 
intervention for reducing the severity of the disability. 
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PROFORMA  (ANNEXURE) 
 
NEURO DEVELOPMENTAL OUTCOME IN CHILDREN WITH 
BIRTH ASPHYXIA 
 
NAME :     I.P. NO.  : 
 
AGE  :     ADDRESS : 
 
SEX  :      
 
ANTENATAL H/O 
 
1. HYPEREMESIS    - Y/N       
 
2. DRUG INTAKE    - Y/N -IFA OTHERS  
 
3. EXANTHEMATOUS ILLNESS - Y/N 
 
4. ANTEPARTUM HEMORRHAGE - Y/N 
 
5. DIABETES MELLITUS   - Y/N  
 
6. HYPERTENSION    - Y/N   
 
7. PREECLAMPSIA    - Y/N  
 
NATAL H/o : 
 
1. PLACE OF DELIVERY   : 
 
2. MODE OF DELIVERY   : NORMAL 
 
        I) ASSISSTED 
        II) CAESAREAN 
 
3. MATERNAL SEDTION   : Y/N 
 
4. MECONIUM STAINED LIQUOR : Y/N 
 
5. CRIED AFTER    : MIN 
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RESUSCITATION: 
 
i) SUCTION &  O2 
ii) BAG & MASK VENTILATION 
iii) BAG & TUBE VENTILATION 
iv) MECHANICAL VENTILATION 
 
APGAR SCORE : 
 
  1 MIN 
  5 MIN 
  20 MIN 
 
BIRTH WEIGHT  : 
 
SIBLING H/o 
 
ON ADMISSION IN NEWBORN UNIT : 
 
1. General Condition  : 
2. Cry    : 
3. Activity   : 
4. Colour   : 
5. HR    : 
6. RR    : 
7. CVS    : 
8. RS    : 
9. P/A    : 
10. CNS    :    TONE 
     NEONATAL REFLEXES 
     ANTERIOR FONTANELLE 
     SPINE & CRANIUM 
 
SARNAT STAGING : 
 
1. CONSCIOUSNESS 
2. MUSCLE TONE 
3. TENDON REFLEXES 
4. MYOCLONUS 
5. SUCKING 
6. MORO RESPONSE 
7. GRAPING 
8. OCULOCEPHALIC REFLEX 
 81
9. PUPILS 
10. RESPIRATION 
11. HEART RATE 
12. CONVULSION 
 
INVESTIGATIONS : 
 
 ULTRA SOUND CRANIUM 
  
 ELECTRO ENCEPHALOGRAM 
 
TRIVANDRUM DEVELOPMENTAL SCREENING CHART – 
 BASED FOLLOW UP 
 
H/O 
  
 MILESTONES  : 
 
 CONVULSIONS  : 
 
 OTHERS   : 
 
EXAMINATION : 
 
 HEAD CIRCUMFERENCE : 
 TONE    : 
 POWER    : 
 DTR     : 
 PLANTAR    : 
 NEONATAL REFLEXES : 
 VISION    : 
 HEARING    : 
 TRIVANDRUM DEVELOPMENTAL SCREENING CHART BASED 
DEVELOPMENTAL ASSESSMENT 
 
RESULTS : 
 
CONCLUSION : 
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ABBREVIATIONS 
 
ADHD  - ATTENTION DEFICIT HYPERACTIVITY DISORDER 
APH   - ANTEPARTUM HEMORRHAGE 
ATP   - ADENOSINE TRIPHOSPHATE 
CDC   - CHILD DEVELOPMENT CENTRE 
CKBB  - CREATINE KINASE BRAIN FRACTION 
CNS   - CENTRAL NERVOUS SYSTEM 
CP   - CEREBRAL PALSY 
CT   - COMPUTED TOMOGRAPHY 
DDST  - DENVER DEVELOPMENT SCREENING TEST 
EEG   - ELECTRO ENCEPHALOGRAM 
HIE   - HYPOXIC ISCHEMIC ENCEPHALOPATHY 
ICH & RC  - INSTITUTE OF CHILD HEALTH RESEARCH CENTRE 
LN   - LABOUR NATURAL 
MRI   - MAGNETIC RESONANCE IMAGING 
NMDA  - N- METHYL,  D – ASPARTATE 
PIH   - PREGNANCY INDUCED HYPERTENSION 
PPV   - POSITIVE PRESSURE VENTILATION 
USG   - ULTRASOUND 
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PERIVENTRICULAR LEUKOMALACIA 
 
 
 
 
 
 
 
 
 
 
 
Coronal sonogram :  Bilateral increased echogenecity just lateral and 
superior to lateral ventricles 
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CEREBRAL EDEMA 
 
 
 
 
 
 
 
 
 
 
Sagittal Sonogram :    Diffuse cerebral edema with silhouetting of 
the sulci 
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1. Revathy M P Forceps P 2.25 5 N R I - 3 N - 
2. Reta Mary M P LSCS A 2.45 10 N R I - 3 N - 
3. Karthiga F A L. N P 2.7 5 N PPV I - 4 N - 
4. Saraswathi M P Forceps A 2.2 10 N R I - 3 N - 
5 Kauupathal M A L. N P 2.3 5 N PPV II N 11 N A 
6 Sakrtabanu M P L. N P 2.6 20 Y PPV III N 13 N A 
7 Dhanalakshmi F A Forceps A 2.2 20 N R II N 6 N N 
8 Mardayee M A L. N A 3.4 5 N PPV II N 8 N A 
9 Muthumari F P L. N A 2.4 5 N R I  3 N  
10 Devi shree F A L. N A 2.75 20 N R II N 12 N N 
11 Venkateswari F P LSCS A 2.25 20 Y PPV II Y 11 N A 
12 Sevanammal M A L. N A 2.8 5 N R II N 8 N A 
13 Aruna M P L. N P 2.8 10 N PPV II N 7 N N 
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14 Eswari M P L. N A 2.1 10 N R I  3 N - 
15 Selvi F A LSCS A 2.55 20 y PPV II Y 11 N A 
16 Durgeswari M A L. N A 2.4 20 N R II Y 7 N A 
17 Valarmathi M A L. N A 2.75 1hr Y PPV III - 14 N A 
18 Muthuselvi M A L. N P 2.25 5 N PPV I - 4 N - 
19 Sri Devi M P L. N P 3.3 20 N PPV II N 7 N N 
20 Jeyarani M A L. N A 2.35 5 N R I - 4 N - 
21 Amirthavalli F P Forceps A 2.8 10 Y PPV III Y 11 N A 
22 Kuruvathal F A L. N A 3.4 10 N PPV II N 6 N N 
23 Nallamani M P L. N A 2.9 1hr N R II N 7 N A 
24 Thulasi F P LSCS A 2.45 5 N R I - 3 N - 
25 Papathi M A L. N P 2.5 >1hr Y PPV II Y 10 A A 
26 Mala M A L. N A 2.3 10 N PPV II N 6 N A 
27 Sumathi F A L. N A 2.5 1hr N R II Y 7 N A 
28 Shanthi M P L. N A 2.25 10 N PPV II N 12 N N 
29 Rakku M A L. N A 3.6 5 N PPV I - 3 N - 
30 Natchiammal F P LSCS A 2.1 20 N R I - 3 N - 
31 Pavalakodi M A L. N A 2.7 20 N R II N 11 N A 
32 Tamilselvi M A L. N A 2.8 10 N PPV II N 7 N A 
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33 Selva meena F P L. N P 3.2 10 N PPV II N 7 N N 
34 Veerajothi M A L. N A 2.75 1hr Y PPV III Y 12 N A 
35 Arokyaselvi F A L. N A 2.6 20 N PPV II N 7 N N 
36 Noorjahan M P L. N P 2.1 5 N R I - 4 N - 
37 Pappa F A LSCS P 3.8 10 N R I - 4 N - 
38 Chellammal M A L. N P 2.4 10 N PPV II N 11 N N 
39 Jeyalakshmi F P L. N A 2.5 1hr Y PPV III - 12 N A 
40 Deepalakshmi  F A L. N A 3.5 20 N PPV II N 7 N N 
41 Veerammal M A Forceps A 2.3 1hr N PPV II Y 11 A A 
42 Vijayalakshmi M A L. N A 2.7 5 N R I - 5 N - 
43 Saradha M P L. N P 3.9 20 N R I - 5 N - 
44 Thangam F A L. N A 2.1 1hr N R II Y 12 N N 
45 Kanimozhi M A L. N A 2.8 5 N PPV II N 7 N N 
46 Katheeja F A L. N P 2.5 1hr N PPV II Y 12 N N 
47 Aarthi F A LSCS A 2.2 >1hr Y PPV III - 11 A A 
48 Durgeswari M P L. N A 2.9 5 N R II N 8 N N 
49 Jeyarani M A L. N A 2.35 20 N R I - 3 N - 
50 Muthuselvi F A Forceps P 3.2 1hr Y PPV II Y 7 A A 
51 Vasanthi M A L. N A 2.4 5 N PPV II N 6 N N 
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52 Chellammal M P L. N A 2.6 10 N PPV II N 7 N N 
53 Sundari F A L. N A 2.25 10 N R I - 3 N - 
54 Sikkandar Beevi M A L. N A 2.7 >1hr Y PPV II Y 11 N A 
55 Vairamani F P L. N A 2.1 >1hr y PPV II Y 7 N A 
56 Lakshmi M A L. N A 2.8 5 N PPV I - 3 N - 
57 Muthumari M P LSCS p 2.4 5 N R I - 4 N - 
58 Jyothi F A L. N A 2.9 10 N R I - 4 N - 
59 Maruthu pandi M A L. N A 2.3 10 N PPV I - 5 N - 
60 Chitra M P L. N A 3.5 5 N R I - 5 N - 
61 Periyanatchi F P L. N A 2.2 10 N R I - 5 N - 
62 Raja lakshmi M A Forceps A 2.5 5 N R I - 5 N - 
63 Vanilla M A L. N A 2.2 5 N R II - 4 N - 
64 Pandi F A L. N A 2.6 1hr N R II Y 7 N A 
65 Thangam F P LSCS A 3.45 20 N PPV II Y 12 N A 
66 Irulayee M A L. N A 2.5 20 N PPV II N 6 N N 
67 Devi M A L. N P 2.4 1hr Y PPV II - 14 N A 
68 Amutha M A L. N A 2.8 10 N PPV III N 7 N N 
69 Latha F A L. N A 2.5 5 N R I - 3 N - 
70 Sangeetha F P LSCS A 2.2 >1hr Y PPV I Y 11 N A 
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71 Manimegalai M A L. N A 2.6 5 N PPV I - 3 N - 
72 Pandimeena M P L. N A 2.7 5 N R I - 5 N - 
73 Akila M A L. N A 2.9 >1hr N R II Y 9 N A 
74 Ponnazhaghu M A L. N A 2.5 10 N R I - 4 N - 
75 Gandhimathi M A L. N A 2.5 1hr N PPV III - 12 N A 
76 Muneeswari F A L. N A 2.6 1hr Y PPV III - 11 N A 
77 Selvi M A L. N P 2.3 10 N PPV I - 4 N - 
78 Annalakshmi M A L. N P 2.7 20 N R I - 4 N A 
79 Panchavarnam M A L. N A 3.1 5 N PPV II N 10 N - 
80 Meena F A Forceps A 2.4 5 N PPV I - 3 N - 
81 Vasuki M P L. N A 2.8 10 N R I - 5 N - 
82 Priya F A L. N A 2.9 10 N PPV I - 4 N A 
83 Lakshmi M A L. N A 2.3 1hr Y PPV III - 11 N A 
84 Divya F P L. N A 2.5 20 N PPV II N 8 N N 
85 Vanitha F A L. N P 2.9 1hr N R II N 8 N A 
86 Mahalakshmi M A LSCS P 3.75 1hr Y PPV I Y 12 A A 
87 Rani M A L. N A 2.7 20 Y PPV I N 11 N A 
88 Jeyasudha M P L. N A 2.2 5 N PPV II - 3 N - 
89 Mareeswari F A L. N A 2.8 5 N PPV II - 4 N - 
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90 Fathima M A L. N A 2.7 >1hr Y PPV II Y 7 N A 
91 Kavitha F P Forceps A 2.6 20 Y PPV III - 13 N N 
92 Thiraviyam M A L. N A 2.1 1hr N PPV II Y 9 A A 
93 Kamatchi F A L. N A 2.5 >1hr N PPV II Y 11 N N 
94 Vasantha M A L. N A 2.6 1hr N R II N 8 N N 
95 Raghavi M A L. N A 2.8 20 N PPV II Y 14 N N 
96 Vimala M A L. N P 2.2 1hr Y PPV III - 9 A N 
97 Muneeswari M A L. N A 2.9 10 N PPV I - 3 N - 
98 Jeyasheela F P LSCS A 3.2 10 N PPV I - 3 N - 
99 Anuratha M A L. N A 2.3 20 Y PPV III - 12 A N 
100 Mageswari F A L. N A 2.6 10 N PPV I - 4 N - 
               
 
Y - YES      P - PRESENT 
N - NO      A - ABSENT 
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FOCAL EPILEPTIFORM DISCHARGES 
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OTOACOUSTIC EMISSION TEST 
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